These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 5860857)

  • 21. [Study of the antitubercular activity of synthetic organic compounds belonging to the group based on Shiff, oxine and anilides].
    Rotmistrov MM; Drabkina RI; Kulik GV; Ginzburg TS; Skrinik EM
    Mikrobiol Zh; 1975; 37(3):385-6. PubMed ID: 1214663
    [No Abstract]   [Full Text] [Related]  

  • 22. [Changes in the lipid metabolic indices as affected by tuberculosis and the action of antitubercular preparations in an experiment].
    Solov'eva TN; Malakhova MIa
    Probl Tuberk; 1984 Mar; (3):56-60. PubMed ID: 6718347
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapeutic efficiency of ethionamide and prothionamide].
    Kozulitsyna TI; Zemskova ZS
    Probl Tuberk; 1969; 47(8):66-9. PubMed ID: 5375685
    [No Abstract]   [Full Text] [Related]  

  • 24. [Changes in the biotin and inositol content of tissues of healthy and tubercular guinea pigs during administration of antibacterial preparations].
    Kruchakova FA
    Probl Tuberk; 1970; 48(7):49-54. PubMed ID: 5486082
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of administration of more tuberculostatics on experimental tuberculosis].
    Durisić M; Drndarski K; Leposavić V
    Glas Srp Akad Nauka Med; 1969; (22):125-36. PubMed ID: 5202709
    [No Abstract]   [Full Text] [Related]  

  • 26. [Various indicators of the immunological response of the body after inclusion of pathogenetic agents in the chemotherapy of tuberculosis].
    Sibirnaia RI; Beliakova OI
    Probl Tuberk; 1984 Sep; (9):28-30. PubMed ID: 6334296
    [No Abstract]   [Full Text] [Related]  

  • 27. [Study on the antituberculous activity of Tuberactin, a new antibiotic].
    Toyohara M
    Kekkaku; 1968 Jul; 43(7):245-8. PubMed ID: 5727835
    [No Abstract]   [Full Text] [Related]  

  • 28. [Glucose-6-phosphatase activity in tuberculosis-infected animals during long-term use of bacteriostatic agents and group B vitamins].
    Romaniuk SL
    Probl Tuberk; 1971; 49(1):76-9. PubMed ID: 4325146
    [No Abstract]   [Full Text] [Related]  

  • 29. Antituberculous effect of some imidazole derivatives.
    Abdel Kader MM; Suleiman KM; Elian SA; Shouab S; El-Moursi BA; Halawa F
    Kekkaku; 1978 Oct; 53(10):499-502. PubMed ID: 102862
    [No Abstract]   [Full Text] [Related]  

  • 30. [Changes in the fibronectin level of the blood and bronchoalveolar lavage fluid in experimental tuberculosis in guinea pigs].
    Kaminskaia GO; Grigor'eva EV; Gedymin LE; Sivakov AE
    Probl Tuberk; 1993; (1):50-4. PubMed ID: 8327442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Experimental therapy with so-called "minor" tuberculostatics].
    Freerksen E
    Wien Med Wochenschr; 1966 Oct; 116(42):874-7. PubMed ID: 6005730
    [No Abstract]   [Full Text] [Related]  

  • 32. [Use of isoniazid derivatives synthesized using carbohydrate-type monomeric matrices as a base in experimental tuberculosis].
    Priĭmak AA; Suvorova VI; Sokolova GB; Braude VI; Antipov IuP
    Probl Tuberk; 1983 Jul; (7):55-8. PubMed ID: 6634678
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of sodium nucleinate on the development of morphologic reactions during antibacterial therapy of experimental tuberculosis].
    Baranova TV
    Probl Tuberk; 1986; (12):46-50. PubMed ID: 3823082
    [No Abstract]   [Full Text] [Related]  

  • 34. Liposome-based antitubercular drug therapy in a guinea pig model of tuberculosis.
    Pandey R; Sharma S; Khuller GK
    Int J Antimicrob Agents; 2004 Apr; 23(4):414-5. PubMed ID: 15081096
    [No Abstract]   [Full Text] [Related]  

  • 35. [An experimental intermittent method of treating tuberculosis].
    Shlapak PT; Belinskiĭ AN
    Probl Tuberk; 1971; 49(12):75-7. PubMed ID: 5159695
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of experimental use of antitubercular preparations and various pathogenetic drugs on the immunological reactions of the body].
    Beliakova OI; Kharakter ZhZ; Sibirnaia RI; Snitinskaia OS
    Probl Tuberk; 1988; (4):65-8. PubMed ID: 3262223
    [No Abstract]   [Full Text] [Related]  

  • 37. [CLINICAL EXPERIENCE WITH 4,4'-DIISOAMYLOXYTHIOCARBANILIDE (ISOXYL) IN PULMONARY TUBERCULOSIS].
    HORNUNG S; OWSINSKI J
    Gruzlica (1926); 1963 Jul; 31():173-80. PubMed ID: 14072804
    [No Abstract]   [Full Text] [Related]  

  • 38. Nanotechnology based drug delivery system(s) for the management of tuberculosis.
    Pandey R; Khuller GK
    Indian J Exp Biol; 2006 May; 44(5):357-66. PubMed ID: 16708887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Relations between the indices of cellular immunity during chemotherapy of experimental tuberculosis].
    Gavrilenko AF; Stasiuk IM; Sibirnaia RI; Beliakova OI
    Probl Tuberk; 1983 Sep; (9):61-3. PubMed ID: 6647448
    [No Abstract]   [Full Text] [Related]  

  • 40. [Preclinical evaluation of alboverticillin, triculamine, and o-carbamyl-d-serine as a new antituberculous antibiotic].
    Kanai K; Koseki Y; Nakamura R; Okamoto S; Murohashi T
    Kekkaku; 1967 Jan; 42(1):37-42. PubMed ID: 6036570
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.